These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

534 related items for PubMed ID: 1346164

  • 21. Attenuated renal excretory response to atrial natriuretic peptide in congestive heart failure in man.
    Eiskjaer H, Bagger JP, Danielsen H, Jensen JD, Jespersen B, Thomsen K, Pedersen EB.
    Int J Cardiol; 1991 Oct; 33(1):61-74. PubMed ID: 1657800
    [Abstract] [Full Text] [Related]

  • 22. Effects of atrial natriuretic peptide (ANP) during converting enzyme inhibition.
    Hansell P, Ulfendahl HR.
    Acta Physiol Scand; 1987 Jul; 130(3):393-9. PubMed ID: 2957891
    [Abstract] [Full Text] [Related]

  • 23. The interaction between atrial natriuretic peptides and angiotensin II in controlling sodium and water excretion in the rat.
    Chamienia AL, Johns EJ.
    Br J Pharmacol; 1991 Aug; 103(4):1893-8. PubMed ID: 1833019
    [Abstract] [Full Text] [Related]

  • 24. Renal function after myocardial infarction and cardiac arrest in rats: role of ANP-induced albuminuria?
    Nielsen SH, Magid E, Spannow J, Christensen S, Lam HR, Petersen JS.
    Acta Physiol Scand; 1997 Aug; 160(4):301-10. PubMed ID: 9338510
    [Abstract] [Full Text] [Related]

  • 25. The effects of human atrial 28-amino acid peptide on systemic and renal hemodynamics in anesthetized rats.
    Hirata Y, Ishii M, Sugimoto T, Matsuoka H, Sugimoto T, Kangawa K, Matsuo H.
    Circ Res; 1985 Oct; 57(4):634-9. PubMed ID: 2931210
    [Abstract] [Full Text] [Related]

  • 26. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion.
    Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, Pandey KN.
    Am J Physiol Renal Physiol; 2003 Oct; 285(4):F694-702. PubMed ID: 12824076
    [Abstract] [Full Text] [Related]

  • 27. Renal and hemodynamic effects of synthetic atrial natriuretic peptide in dogs with chronic renal failure.
    Tsuchiya K, Sanaka T, Ando A.
    Nihon Jinzo Gakkai Shi; 1989 Feb; 31(2):151-7. PubMed ID: 2525634
    [Abstract] [Full Text] [Related]

  • 28. Attenuated diuretic and natriuretic effects of atrial natriuretic peptide in rats with heart failure.
    Tikkanen T, Tikkanen I, Sariola H, Svartström-Fraser M, Fyhrquist F.
    Horm Metab Res; 1989 Apr; 21(4):185-8. PubMed ID: 2526789
    [Abstract] [Full Text] [Related]

  • 29. Renal and cardiovascular effects of atrial natriuretic peptide in fetal sheep.
    Hargrave BY, Iwamoto HS, Rudol AM.
    Pediatr Res; 1989 Jul; 26(1):1-5. PubMed ID: 2528111
    [Abstract] [Full Text] [Related]

  • 30. Renal effects of urodilatin and atrial natriuretic peptide in volume expanded conscious dogs.
    Bestle MH, Bie P.
    Acta Physiol Scand; 1993 Sep; 149(1):77-83. PubMed ID: 8237425
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Captopril restores hemodynamic responsiveness to atrial natriuretic peptide in rats with heart failure.
    Raya TE, Lee RW, Westhoff T, Goldman S.
    Circulation; 1989 Dec; 80(6):1886-92. PubMed ID: 2532077
    [Abstract] [Full Text] [Related]

  • 34. The dopamine receptor antagonist haloperidol blocks natriuretic but not hypotensive effects of the atrial natriuretic factor.
    Hansell P, Fasching A, Sjöquist M, Andén NE, Ulfendahl HR.
    Acta Physiol Scand; 1987 Jul; 130(3):401-7. PubMed ID: 2957892
    [Abstract] [Full Text] [Related]

  • 35. Atrial natriuretic peptide in rats with experimental cirrhosis of the liver without ascites.
    Olivera A, Gutkowska J, Rodriguez-Puyol D, Fernandez-Cruz A, López-Novoa JM.
    Endocrinology; 1988 Mar; 122(3):840-6. PubMed ID: 2963741
    [Abstract] [Full Text] [Related]

  • 36. Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure.
    Drexler H, Finkh M, Höing S, Toth M, Just H, Lang RE.
    Basic Res Cardiol; 1987 Mar; 82(6):517-29. PubMed ID: 2963615
    [Abstract] [Full Text] [Related]

  • 37. Hemodynamic, renal, and endocrine effects of 4-h infusions of human atrial natriuretic peptide in normal volunteers.
    Bidiville J, Waeber G, Porchet M, Nussberger J, Biollaz J, Gomez H, Callahan L, Waeber B, Brunner HR.
    Fundam Clin Pharmacol; 1988 Mar; 2(5):413-29. PubMed ID: 2976727
    [Abstract] [Full Text] [Related]

  • 38. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
    Riegger GA, Elsner D, Kromer EP, Daffner C, Forssmann WG, Muders F, Pascher EW, Kochsiek K.
    Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure.
    Abassi Z, Haramati A, Hoffman A, Burnett JC, Winaver J.
    Am J Physiol; 1990 Jul; 259(1 Pt 2):R84-9. PubMed ID: 2142862
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.